🔴 Decoy Therapeutics is trading 7.6% down with no clear company-specific catalyst identified

Decoy Therapeutics is trading 7.6% lower at $1.82, with no clear company-specific catalyst identified for the October 1 decline.

• The CEO presentation at The Small Cap Showcase was scheduled for October 1; a September 29 preclinical update discussed once-weekly dosing. Neither establishes a link to the drop.
• Major indices were nearly flat and do not clearly explain the move. The stock has fallen in recent sessions, but why selling continues is unconfirmed; trading-volume details were unavailable.